Artefacts in longitudinal MRI of the brain
Many drugs are under development to treat Alzheimer's disease (AD), the prevalent cause of dementia. Cognitive tests are the established way of assessing drug efficacy. More sensitive, quantitative measures, biomarkers, are desirable for faster assessment of efficacy from smaller cohorts. AD is...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498310 |